REFERENCES
1. Harding C, Heuser J, Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol. 1983;97:329-39.
2. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262:9412-20.
3. Dragovic RA, Gardiner C, Brooks AS, et al. Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomedicine. 2011;7:780-8.
4. Sokolova V, Ludwig AK, Hornung S, et al. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces. 2011;87:146-50.
5. Coumans FA, van der Pol E, Böing AN, et al. Reproducible extracellular vesicle size and concentration determination with tunable resistive pulse sensing. J Extracell Vesicles. 2014;3:25922.
6. Hood JL, Pan H, Lanza GM, Wickline SA; Consortium for Translational Research in Advanced Imaging and Nanomedicine (C-TRAIN). Paracrine induction of endothelium by tumor exosomes. Lab Invest. 2009;89:1317-28.
7. Droste M, Tertel T, Jeruschke S, et al. Single extracellular vesicle analysis performed by imaging flow cytometry and nanoparticle tracking analysis evaluate the accuracy of urinary extracellular vesicle preparation techniques differently. Int J Mol Sci. 2021;22:12436.
8. Srinivasan S, Yeri A, Cheah PS, et al. Small RNA sequencing across diverse biofluids identifies optimal methods for exRNA isolation. Cell. 2019;177:446-62.e16.
9. Breitwieser K, Koch LF, Tertel T, et al. Detailed characterization of small extracellular vesicles from different cell types based on tetraspanin composition by ExoView R100 platform. Int J Mol Sci. 2022;23:8544.
10. Helmink BA, Reddy SM, Gao J, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-55.
11. Tian Y, Ma L, Gong M, et al. Protein profiling and sizing of extracellular vesicles from colorectal cancer patients via flow cytometry. ACS Nano. 2018;12:671-80.
12. Görgens A, Bremer M, Ferrer-Tur R, et al. Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material. J Extracell Vesicles. 2019;8:1587567.
13. Ricklefs FL, Maire CL, Reimer R, et al. Imaging flow cytometry facilitates multiparametric characterization of extracellular vesicles in malignant brain tumours. J Extracell Vesicles. 2019;8:1588555.
14. Welsh JA, Arkesteijn GJA, Bremer M, et al. A compendium of single extracellular vesicle flow cytometry. J Extracell Vesicles. 2023;12:e12299.
15. Welsh JA, Van Der Pol E, Arkesteijn GJA, et al. MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments. J Extracell Vesicles. 2020;9:1713526.
16. Tertel T, Bremer M, Maire C, et al. High-resolution imaging flow cytometry reveals impact of incubation temperature on labeling of extracellular vesicles with antibodies. Cytometry A. 2020;97:602-9.
17. Tertel T, Schoppet M, Stambouli O, Al-Jipouri A, James PF, Giebel B. Imaging flow cytometry challenges the usefulness of classically used extracellular vesicle labeling dyes and qualifies the novel dye Exoria for the labeling of mesenchymal stromal cell-extracellular vesicle preparations. Cytotherapy. 2022;24:619-28.
18. Tertel T, Tomić S, Đokić J, et al. Serum-derived extracellular vesicles: novel biomarkers reflecting the disease severity of COVID-19 patients. J Extracell Vesicles. 2022;11:e12257.
19. Gundtoft PH, Overgaard S, Schønheyder HC, Møller JK, Kjærsgaard-Andersen P, Pedersen AB. The “true” incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties: a prospective cohort study. Acta Orthop. 2015;86:326-34.
20. Busch A, Jäger M, Wegner A, Haversath M; VITAS group. Vitamin E-blended versus conventional polyethylene liners in prostheses : prospective, randomized trial with 3-year follow-up. Orthopade 2020;49:1077-85.
21. Busch A, Jäger M, Klebingat S, et al; VITAS-Group. Vitamin E-blended highly cross-linked polyethylene liners in total hip arthroplasty: a randomized, multicenter trial using virtual CAD-based wear analysis at 5-year follow-up. Arch Orthop Trauma Surg. 2020;140:1859-66.
22. Mbalaviele G, Novack DV, Schett G, Teitelbaum SL. Inflammatory osteolysis: a conspiracy against bone. J Clin Invest. 2017;127:2030-9.
23. Tetreault MW, Estrera KA, Kayupov E, Brander C, Della Valle CJ. Are patients being evaluated for periprosthetic joint infection prior to referral to a tertiary care center? Arthroplast Today. 2018;4:216-20.
24. Parvizi J, Jacovides C, Antoci V, Ghanem E. Diagnosis of periprosthetic joint infection: the utility of a simple yet unappreciated enzyme. J Bone Joint Surg Am. 2011;93:2242-8.
25. Kildow BJ, Springer BD, Brown TS, Lyden E, Fehring TK, Garvin KL. Long term results of two-stage revision for chronic periprosthetic hip infection: a multicenter study. J Clin Med. 2022;11:1657.
26. Bjerke-Kroll BT, Christ AB, McLawhorn AS, Sculco PK, Jules-Elysée KM, Sculco TP. Periprosthetic joint infections treated with two-stage revision over 14 years: an evolving microbiology profile. J Arthroplasty. 2014;29:877-82.
27. Sigmund IK, Luger M, Windhager R, McNally MA. Diagnosing periprosthetic joint infections: a comparison of infection definitions: EBJIS 2021, ICM 2018, and IDSA 2013. Bone Joint Res. 2022;11:608-18.
28. Yuan K, Chen HL, Cui ZM. Diagnostic accuracy of C-reactive protein for periprosthetic joint infection: a meta-analysis. Surg Infect. 2014;15:548-59.
29. Kheir MM, Tan TL, Shohat N, Foltz C, Parvizi J. Routine diagnostic tests for periprosthetic joint infection demonstrate a high false-negative rate and are influenced by the infecting organism. J Bone Joint Surg Am. 2018;100:2057-65.
30. Glehr M, Friesenbichler J, Hofmann G, et al. Novel biomarkers to detect infection in revision hip and knee arthroplasties. Clin Orthop Relat Res. 2013;471:2621-8.
31. Patel R, Alijanipour P, Parvizi J. Advancements in diagnosing periprosthetic joint infections after total hip and knee arthroplasty. Open Orthop J. 2016;10:654-61.
32. Cats-Baril W, Gehrke T, Huff K, Kendoff D, Maltenfort M, Parvizi J. International consensus on periprosthetic joint infection: description of the consensus process. Clin Orthop Relat Res. 2013;471:4065-75.
33. Bilgen O, Atici T, Durak K, Karaeminoğullari
34. Larsson S, Thelander U, Friberg S. C-reactive protein (CRP) levels after elective orthopedic surgery. Clin Orthop Relat Res. 1992;275:237-42.
35. Parvizi J, Zmistowski B, Berbari EF, et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011;469:2992-4.
36. Yáñez-Mó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.
37. Fais S, O’Driscoll L, Borras FE, et al. Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine. ACS Nano. 2016;10:3886-99.
38. Varela L, van de Lest CHA, van Weeren PR, Wauben MHM. Synovial fluid extracellular vesicles as arthritis biomarkers: the added value of lipid-profiling and integrated omics. Extracell Vesicles Circ Nucl Acids. ;5:276-96.
39. Kolhe R, Owens V, Sharma A, et al. Sex-specific differences in extracellular vesicle protein cargo in synovial fluid of patients with osteoarthritis. Life. 2020;10:337.
40. Sallai I, Marton N, Szatmári A, et al. Activated polymorphonuclear derived extracellular vesicles are potential biomarkers of periprosthetic joint infection. PLoS One. 2022;17:e0268076.
41. Rüwald JM, Randau TM, Hilgers C, et al. Extracellular vesicle isolation and characterization from periprosthetic joint synovial fluid in revision total joint arthroplasty. J Clin Med. 2020;9:516.
42. Tan TL, Kheir MM, Shohat N, et al. Culture-negative periprosthetic joint infection: an update on what to expect. JB JS Open Access. 2018;3:e0060.
43. Collins R, Balaconis MK, Brunak S, et al. Global priorities for large-scale biomarker-based prospective cohorts. Cell Genom. 2022;2:100141.
44. Logozzi M, De Milito A, Lugini L, et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One. 2009;4:e5219.
45. Ong J, Tang A, Rozell JC, Babb JS, Schwarzkopf R, Lin D. Factors predicting hip joint aspiration yield or “dry taps” in patients with total hip arthroplasty. J Orthop Surg Res. 2022;17:42.
46. Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014;14:195-208.
